Edgewise Therapeutics, Inc. Lock-Up Agreement September 12, 2022Orbimed Advisors LLC • September 16th, 2022 • Pharmaceutical preparations • New York
Company FiledSeptember 16th, 2022 Industry JurisdictionThe undersigned understands that J.P. Morgan Securities LLC and SVB Securities LLC, as representatives (the “Representatives”), propose to enter into an underwriting agreement (the “Underwriting Agreement”) on behalf of the several Underwriters named in Schedule I to such agreement (collectively, the “Underwriters”), with Edgewise Therapeutics, Inc., a Delaware corporation (the “Company”), providing for a public offering (the “Public Offering”) of shares of the Common Stock of the Company (the “Shares”) pursuant to a shelf Registration Statement on Form S-3 that has been previously filed with the Securities and Exchange Commission (the “SEC”).
Edgewise Therapeutics, Inc. Lock-Up AgreementNovo Holdings a/S • March 31st, 2021 • Pharmaceutical preparations • New York
Company FiledMarch 31st, 2021 Industry Jurisdiction